Predictive markers in breast and other cancers: a review.
about
Real-time PCR complements immunohistochemistry in the determination of HER-2/neu status in breast cancerRenal tumors: diagnostic and prognostic biomarkersConstitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancerThe NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells.The plasminogen system in microdissected colonic mucosa distant from an isolated adenoma.Differential expression of p42.3 in low- and high-grade gliomasIntegrative analysis of copy number and gene expression in breast cancer using formalin-fixed paraffin-embedded core biopsy tissue: a feasibility study.Activatable molecular systems using homologous near-infrared fluorescent probes for monitoring enzyme activities in vitro, in cellulo, and in vivo.Molecular imaging in therapeutic efficacy assessment of targeted therapy for nonsmall cell lung cancerUse of positron emission tomography to target prostate cancer gene therapy by oncolytic herpes simplex virus.Growth factor receptors and apoptosis regulators: signaling pathways, prognosis, chemosensitivity and treatment outcomes of breast cancer.Prediction of poor prognosis in breast cancer patients based on microRNA-21 expression: a meta-analysis.Assessment of ERBB2 and EGFR gene amplification and protein expression in gastric carcinoma by immunohistochemistry and fluorescence in situ hybridization.The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study.Reliable gene expression profiling of formalin-fixed paraffin-embedded breast cancer tissue (FFPE) using cDNA-mediated annealing, extension, selection, and ligation whole-genome (DASL WG) assayChanges in the in vitro activity of platinum drugs when administered in two aliquots.MALDI-MS-Based Profiling of Serum Proteome: Detection of Changes Related to Progression of Cancer and Response to Anticancer Treatment.Assessing treatment-selection markers using a potential outcomes framework.Elevated Serum Levels of Retinol-Binding Protein 4 Are Associated with Breast Cancer Risk: A Case-Control StudyDevelopment of new predictive markers for endocrine therapy and resistance in breast cancer.Applications of machine learning in cancer prediction and prognosisAntineoplastic effect of iodine in mammary cancer: participation of 6-iodolactone (6-IL) and peroxisome proliferator-activated receptors (PPAR)Cancer biomarker HER-2/neu in breast cancer in Indian womenLigand-dependent corepressor LCoR is an attenuator of progesterone-regulated gene expression.Intrinsic resistance to chemotherapy in breast cancer.Proliferation signal inhibitors and post-transplant malignancies in heart transplantation: practical clinical management questions.Tumor markers in clinical practice: a review focusing on common solid cancersDesign and evaluation of radiolabeled tracers for tumor imaging.Differentiation-inducing factor-1 enhances 5-fluorouracil action on oral cancer cells inhibiting E2F1 and thymidylate synthase mRNAs accumulation.Predictive tests for individualization of pharmacological cancer treatment.Mammalian lignans enterolactone and enterodiol, alone and in combination with the isoflavone genistein, do not promote the growth of MCF-7 xenografts in ovariectomized athymic nude mice.An optimized image analysis algorithm for detecting nuclear signals in digital whole slides for histopathology.Cell cycle dysregulation influences survival in high risk breast cancer patients.Correlation of Molecular Subtypes of Invasive Ductal Carcinoma of Breast with Glucose Metabolism in FDG PET/CT: Based on the Recommendations of the St. Gallen Consensus Meeting 2013.The role of Ly49E receptor expression on murine intraepithelial lymphocytes in intestinal cancer development and progression.Prognostic value and clinicopathological significance of serum- and tissue-based cytokeratin 18 express level in breast cancer: a meta-analysis.Estrogen receptors: role in breast cancer.HER-2 protein overexpressing breast cancer without gene amplification shows higher hormone receptor expression than HER-2 protein overexpressing breast cancer with gene amplification.
P2860
Q25257296-405A0505-B11B-4F5D-8D76-7C575C6198CCQ26860500-F8DF89A6-6887-4536-B53E-281566F4EDE8Q28475229-D21C31D7-5B7D-4FE0-A812-15EBB505C75FQ30479321-A8D4793D-9DEB-43CD-BB39-DB68BF12FB82Q33585332-F629E186-9C8F-4240-8248-0415FD9A7780Q33813843-01D86148-B39C-4654-941E-EADDD8FBBE7BQ33896397-4A62D895-5F61-41FD-A95C-6D19D713E083Q34032588-5A84A68D-310B-46EA-860B-8AA00A59BF62Q34243500-8752307D-826F-4BDF-AD31-8EBD83A12F54Q34441869-0E5DA413-A298-455B-A95A-40A23A717F68Q34908845-78DDCFC8-B662-4AA2-A779-249572806E2FQ35112630-45DB3683-2314-4435-B479-DE6114C25C5DQ35122508-8B3C306B-9574-4472-B381-FFB725A47FB3Q35206311-D2CF445F-5BE2-403A-BC82-601EB0F257D5Q35558983-6CFFBAB8-09F8-41A0-A0E7-94A269A16CBFQ36108057-B51961CE-362E-4DC0-A66C-8A063A0B7949Q36114723-4CB59784-393A-44E3-BF33-56F46C9C2EF0Q36147848-DE01D6B1-3E33-44F1-A310-70D5C14883F9Q36157844-74703311-143B-4F9B-9952-BF9D895585FAQ36230381-5471A573-9558-4B84-92B0-0C20DF559D42Q37157598-DF27CBC7-85FB-4946-870C-A4F8F7635775Q37175004-F3E68E91-EA24-4AD4-82E4-D3DDA04538A0Q37244935-F1002283-563E-4F5F-8E21-5CE444979CD3Q37356034-308F7237-5777-40A7-9DF3-8938797C1753Q37431722-FDD5226E-6872-4B2F-964C-1545DE90084BQ37813694-2246A6C9-47A3-453B-8501-F779CB400C60Q37876951-21B68EF2-B44B-41B1-8EF3-72A5CCC9D8C9Q38010046-F84954AD-CDC7-49F2-A88E-AA8D7E1B85BEQ38137253-E8F0432A-1BBC-4BB5-AF6B-C9BF380D5205Q39433347-7F90B57E-3898-434D-B778-E9C0B3A038D0Q40109282-6A5151A6-6DC6-4C00-AEC3-0225C5489D8AQ40375582-7E311E65-C225-423E-8EC3-1F29639AC342Q40466552-05E9B345-5ABD-4CA5-AAD3-D75623C0771BQ45225407-2CBCDA8E-374B-40F6-8689-3C695A05E249Q48175913-427A9BAC-A8AF-466C-894A-E8CA750ADB24Q48293366-1309B982-BE1C-4A70-BF51-D68A6A2E007EQ50043508-7254AD7B-77F1-4694-BAC3-DF00CB477C79Q53595317-E012EF5D-1381-4750-9D9E-0A3FFC65734FQ54727540-69186303-4647-4C85-9397-511A8CBF649F
P2860
Predictive markers in breast and other cancers: a review.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Predictive markers in breast and other cancers: a review.
@ast
Predictive markers in breast and other cancers: a review.
@en
Predictive markers in breast and other cancers: a review.
@nl
type
label
Predictive markers in breast and other cancers: a review.
@ast
Predictive markers in breast and other cancers: a review.
@en
Predictive markers in breast and other cancers: a review.
@nl
prefLabel
Predictive markers in breast and other cancers: a review.
@ast
Predictive markers in breast and other cancers: a review.
@en
Predictive markers in breast and other cancers: a review.
@nl
P1433
P1476
Predictive markers in breast and other cancers: a review.
@en
P2093
Michael J Duffy
P304
P356
10.1373/CLINCHEM.2004.046227
P407
P577
2005-01-06T00:00:00Z